Demographic differences in prostate cancer incidence and stage: An examination of population diversity in California

被引:17
作者
Delfino, RJ [1 ]
Ferrini, RL
Taylor, TH
Howe, S
Anton-Culver, H
机构
[1] Univ Calif Irvine, Coll Med, Dept Med, Div Epidemiol, Irvine, CA 92697 USA
[2] San Diego State Univ, Grad Sch Publ Hlth, Dept Family & Prevent Med, San Diego, CA 92182 USA
[3] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA
关键词
prostate; neoplasm; incidence; income; race; ethnicity;
D O I
10.1016/S0749-3797(97)00014-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Geographic and racial/ethnic variability in prostate cancer incidence rates and stage distribution ma;ri be partly attributed to differences in screening and ear ly detection. Methods: Using California Cancer Registry data we aimed to characterize variability in prostate cancer rates statewide and to examine differences in the stage at diagnosis of prostate cancer by racial/ethnic group statewide and by census tract per capita income in San Diego County. We calculated annual average (1988-1991) age-adjusted incidence rates per 100,000 (AAIR) of prostate cancer for 49,880 men over age 34 years. Racial/ethnic groups were compared using incidence rate ratios (IRR) (AAIR localized plus regional stages AAIR distant stage). Results: Statewide, Caucasians showed a higher IRR [6.16, 95% confidence interval (CI), 6.00-6.30] than did African Americans (2.34, 95% CI, 1.89-2.89), Hispanics (3.84, 95% CI; 3,63-4.05), or Asian/others (3.61, 95% CI, 1.80-7.22). Within San Diego County, Caucasians living in higher per capita income census tracts (greater than or equal to 65th percentile) had a significantly higher IRR (8.80, 95% CI 7.84-9.89) than did lower-income tracts (5.68, 95% CI, 5.13-6.30). Conclusion: Findings from the present and similar studies suggest that outcomes research is needed to determine the impact of these demographic differences on prostate cancer mortality and quality of life. This is particularly important given the current controversy regarding the treatment of clinically localized prostate cancers, increasingly found through early detection, which often involve difficult choices between aggressive therapies including prostatectomy or watchful waiting.
引用
收藏
页码:96 / 102
页数:7
相关论文
共 43 条
[1]  
*AM ASS CENTR CANC, 1994, STAND COMPL QUAL AN, V3
[2]  
*AM JOINT COMM CAN, 1988, MAN STAG CANC, P177
[3]  
[Anonymous], SEER EXTENT DIS 1988
[4]   DETECTION OF ORGAN-CONFINED PROSTATE-CANCER IS INCREASED THROUGH PROSTATE-SPECIFIC ANTIGEN-BASED SCREENING [J].
CATALONA, WJ ;
SMITH, DS ;
RATLIFF, TL ;
BASLER, JW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (08) :948-954
[5]   RESULTS OF CONSERVATIVE MANAGEMENT OF CLINICALLY LOCALIZED PROSTATE-CANCER [J].
CHODAK, GW ;
THISTED, RA ;
GERBER, GS ;
JOHANSSON, JE ;
ADOLFSSON, J ;
JONES, GW ;
CHISHOLM, GD ;
MOSKOVITZ, B ;
LIVNE, PM ;
WARNER, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (04) :242-248
[6]   PROSTATE-CANCER - TRENDS IN MORTALITY AND STAGE-SPECIFIC INCIDENCE RATES BY RACIAL ETHNIC-GROUP IN LOS-ANGELES-COUNTY, CALIFORNIA (UNITED-STATES) [J].
DANLEY, KL ;
RICHARDSON, JL ;
BERNSTEIN, L ;
LANGHOLZ, B ;
ROSS, RK .
CANCER CAUSES & CONTROL, 1995, 6 (06) :492-498
[7]   INCREASING INCIDENCE OF CANCER OF THE PROSTATE - THE EXPERIENCE OF BLACK-AND-WHITE MEN IN THE DETROIT METROPOLITAN-AREA [J].
DEMERS, RY ;
SWANSON, GM ;
WEISS, LK ;
KAY, TY .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (11) :1211-1216
[9]  
Fleming C, 1993, JAMA, V269, P2650
[10]  
GILLILAND FD, 1994, CANCER, V73, P2192, DOI 10.1002/1097-0142(19940415)73:8<2192::AID-CNCR2820730826>3.0.CO